Key result
Short-term NO2 exposure is linked to ~1% higher IHD hospitalization risk, attenuated by statins.
Why the study?
The study evaluated whether the association between nitrogen dioxide exposure and ischemic heart disease hospitalization differed by statin-use status among patients with hypertension.
Does statin use modify the risk of short-term NO2 exposure-associated hospitalization for IHD in patients with hypertension?
Case-Control (n=72,753)
No
Does statin use modify the risk of short-term NO2 exposure-associated hospitalization for IHD in patients with hypertension?
Statin use in hypertensive patients is associated with a mitigated risk of short-term NO2-induced ischemic heart disease hospitalization.
Answers are grounded in this paper and cite their sources.
Statin use may attenuate NO2-related IHD risk in hypertension; hypothesis-generating and should not yet change practice.
Background: exposure and ischemic heart disease (IHD) hospitalization differ by statin-use status, focusing on patients with hypertension. Methods: for interaction). Results: for interaction < 0.05). The associations differed by statin-use status, with generally lower, non-significant estimates among statin users. Among non-users, significant positive associations were observed at lag1, lag2, and lag01 (ORs > 1). In contrast, estimates among statin users were lower and non-significant. Conclusions: exposure was associated with an increased risk of hospitalization for IHD among patients with hypertension. However, this association differed by statin-use status, with lower estimates observed among statin users than non-users.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) conducted a case-control in Ischemic heart disease with hypertension (n=72,753). Nitrogen dioxide (NO2) exposure vs. Reference control days was evaluated on Hospitalization for ischemic heart disease per 0.01 ppm increase in daily mean NO2 concentration on admission day (OR 1.012, 95% CI 1.003-1.020). Short-term NO2 exposure increased ischemic heart disease hospitalization risk, but this association was attenuated in statin users compared to non-users.
Synapse has enriched 10 related papers. Consider them for comparative context: